# US 2019/0316103 A1 · GH61 Polypeptide Variants and Polynucleotides Encoding Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0316103 A1
- Document ID: US20190316103A1
- Status: Published application
- Kind: A1
- Application number: 16/420,609
- Filed: 2019-05-23
- Published: 2019-10-17
- Earliest claimed: 2011-11-21
- Assignees: Novozymes, Inc.; Novozymes A/S
- Applicants: Novozymes, Inc.; Novozymes A/S
- Inventors: Janine Lin; Doreen Bohan; Michelle Maranta; Leslie Beresford; Michael Lamsa; Bjarne Gram Hansen; Frank Winther Rasmussen; Matt Sweeney; Douglas J. Boyle III
- Web page: https://patentgrep.com/patent/US20190316103A1

## CPC

- C12N 9/2402: {hydrolysing O- and S- glycosyl compounds (3.2.1)}
- C11D 3/386: Preparations containing enzymes {, e.g. protease or amylase}
- C11D 3/38645: {containing cellulase}
- C11D 3/38681: {Chemically modified or immobilised enzymes}
- C12N 9/0004: {Oxidoreductases (1.)}
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12P 19/02: Monosaccharides (2-ketogulonic acid C12P7/60)
- D21C 5/005: {Treatment of cellulose-containing material with microorganisms or enzymes}
- D21H 17/005: {Microorganisms or enzymes}
- C12Y 101/99: with other acceptors (1.1.99)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C11D: DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- D21C: PRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR
- D21H: PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- C12Y: ENZYMES

## Abstract

The present invention relates to GH61 polypeptide variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.

## Claims

### Claim at position 1

1-21. (canceled)

### Claim 22

A variant GH61 polypeptide having cellulolytic enhancing activity, comprising a substitution at one or more positions corresponding to positions 105, 154, 188, 189, 216, and 229 of the mature polypeptide of SEQ ID NO: 30, wherein the substitution at corresponding position 105 is with Pro or Lys, the substitution at corresponding position 154 is with Ile or Leu, the substitution at corresponding position 188 is with Ala, Phe, Met, or Trp, the substitution at corresponding position 189 is with His or Lys, the substitution at corresponding position 216 is with Leu or Tyr, and the substitution at corresponding position 229 is with Trp, His, Ile, or Tyr, wherein the variant has cellulolytic enhancing activity, wherein the variant has increased thermostability relative to a GH61 polypeptide without the substitution at the one or more positions corresponding to positions 105, 154, 188, 189, 216, and 229 of the mature polypeptide of SEQ ID NO: 30, and wherein the variant has at least 95% sequence identity, but less than 100% sequence identity, to the mature polypeptide of SEQ ID NO: 2, 4, 6, 8, 10, 12, 16, 18, 20, 22, 24, 26, 28, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, or 216.

### Claim 23 (depends on 22)

The variant of claim 22, wherein the variant has at least 96% sequence identity, but less than 100% sequence identity, to the mature polypeptide of the GH61 polypeptide of SEQ ID NO: 2, 4, 6, 8, 10, 12, 16, 18, 20, 22, 24, 26, 28, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, or 216.

### Claim 24 (depends on 22)

The variant of claim 22, wherein the variant has at least 97% sequence identity, but less than 100% sequence identity, to the mature polypeptide of the GH61 polypeptide of SEQ ID NO: 2, 4, 6, 8, 10, 12, 16, 18, 20, 22, 24, 26, 28, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, or 216.

### Claim 25 (depends on 22)

The variant of claim 22, wherein the variant has at least 98% sequence identity, but less than 100% sequence identity, to the mature polypeptide of the GH61 polypeptide of SEQ ID NO: 2, 4, 6, 8, 10, 12, 16, 18, 20, 22, 24, 26, 28, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, or 216.

### Claim 26 (depends on 22)

The variant of claim 22, wherein the variant has at least 99% sequence identity, but less than 100% sequence identity, to the mature polypeptide of the GH61 polypeptide of SEQ ID NO: 2, 4, 6, 8, 10, 12, 16, 18, 20, 22, 24, 26, 28, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, or 216.

### Claim 27 (depends on 22)

The variant of claim 22, which further comprises a substitution at one or more positions corresponding to positions 111, 152, 155, and 162 of the mature polypeptide of SEQ ID NO: 30, wherein the substitution at corresponding position 111 is with Val, the substitution at corresponding position 152 is with Ser, the substitution at corresponding position 155 is with Leu, and the substitution at corresponding position 162 is with Trp, and wherein the variant has cellulolytic enhancing activity.

### Claim 28 (depends on 27)

The variant of claim 27, wherein said variant comprises one or more substitutions or corresponding substitutions selected from the group consisting of a substitution of Leu at position 111 with Val, a substitution of Asp at position 152 with Ser, a substitution of Met at position 155 with Leu, and a substitution of Ala at position 162 with Trp.

### Claim 29 (depends on 22)

The variant of claim 22, wherein the thermostability of the variant is increased at least 1.01-fold compared to the parent.

### Claim 30 (depends on 22)

An isolated polynucleotide encoding the GH61 polypeptide variant of claim 22.

### Claim 31 (depends on 30)

A recombinant host cell transformed with the polynucleotide of claim 30.

### Claim 32 (depends on 31)

A method of producing a GH61 polypeptide variant, comprising: (a) cultivating the recombinant host cell of claim 31 under conditions suitable for expression of the variant; and optionally (b) recovering the variant.

### Claim 33 (depends on 30)

A transgenic plant, plant part or plant cell transformed with the polynucleotide of claim 30.

### Claim 34 (depends on 33)

A method of producing a GH61 polypeptide variant, comprising: (a) cultivating the transgenic plant or a plant cell of claim 33 under conditions conducive for production of the variant; and optionally (b) recovering the variant.

### Claim 35 (depends on 22)

A process for degrading or converting a cellulosic material, comprising: treating the cellulosic material with an enzyme composition comprising the GH61 polypeptide variant having cellulolytic enhancing activity of claim 22.

### Claim 36 (depends on 22)

A process for producing a fermentation product, comprising: (a) saccharifying a cellulosic material with an enzyme composition comprising the GH61 polypeptide variant having cellulolytic enhancing activity of claim 22; (b) fermenting the saccharified cellulosic material with one or more fermenting microorganisms to produce the fermentation product; and (c) recovering the fermentation product from the fermentation.

### Claim 37 (depends on 22)

A process of fermenting a cellulosic material, comprising: fermenting the cellulosic material with one or more fermenting microorganisms, wherein the cellulosic material is saccharified with an enzyme composition comprising the GH61 polypeptide variant having cellulolytic enhancing activity of claim 22.

### Claim 38 (depends on 22)

A whole broth formulation or cell culture composition, comprising the GH61 polypeptide variant of claim 22.

### Claim 39 (depends on 22)

A detergent composition, comprising a surfactant and the GH61 polypeptide variant of claim 22.
